Wellington Management Group LLP Grows Position in Dolby Laboratories $DLB

Wellington Management Group LLP grew its position in Dolby Laboratories (NYSE:DLBFree Report) by 19.4% in the 2nd quarter, HoldingsChannel.com reports. The firm owned 320,156 shares of the electronics maker’s stock after purchasing an additional 52,053 shares during the period. Wellington Management Group LLP’s holdings in Dolby Laboratories were worth $16,834,000 as of its most recent SEC filing.

Other hedge funds have also bought and sold shares of the company. Fifth Third Bancorp raised its stake in shares of Dolby Laboratories by 34.7% during the 4th quarter. Fifth Third Bancorp now owns 746 shares of the electronics maker’s stock worth $48,000 after purchasing an additional 192 shares during the period. Aquatic Capital Management LLC bought a new stake in Dolby Laboratories during the 3rd quarter valued at $56,000. iSAM Funds UK Ltd purchased a new stake in Dolby Laboratories during the 3rd quarter worth about $68,000. Quarry LP lifted its holdings in shares of Dolby Laboratories by 1,486.7% in the fourth quarter. Quarry LP now owns 1,190 shares of the electronics maker’s stock worth $76,000 after buying an additional 1,115 shares in the last quarter. Finally, Advisory Services Network LLC purchased a new stake in Dolby Laboratories in the 3rd quarter worth approximately $102,000. 58.56% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

Several analysts have weighed in on the company. Weiss Ratings cut Dolby Laboratories from a “hold (c-)” rating to a “sell (d+)” rating in a report on Thursday, August 13th. Rosenblatt Securities reissued a “buy” rating and issued a $85.00 price target on shares of Dolby Laboratories in a research note on Friday, August 28th. Wall Street Zen downgraded Dolby Laboratories from a “buy” rating to a “hold” rating in a research report on Saturday, August 1st. Finally, Barrington Research reaffirmed an “outperform” rating and set a $90.00 price objective on shares of Dolby Laboratories in a research note on Monday, June 15th. Two investment analysts have rated the stock with a Buy rating and one has given a Sell rating to the company. Based on data from MarketBeat, Dolby Laboratories currently has a consensus rating of “Hold” and an average price target of $87.50.

Check Out Our Latest Report on Dolby Laboratories

Dolby Laboratories Trading Down 0.2%

Shares of Dolby Laboratories stock opened at $61.81 on Monday. Dolby Laboratories has a 12 month low of $48.26 and a 12 month high of $73.78. The firm has a market capitalization of $5.79 billion, a P/E ratio of 26.30 and a beta of 0.80. The business has a fifty day simple moving average of $56.58 and a two-hundred day simple moving average of $58.27.

Dolby Laboratories (NYSE:DLBGet Free Report) last posted its quarterly earnings data on Thursday, July 30th. The electronics maker reported $0.69 EPS for the quarter, topping the consensus estimate of $0.67 by $0.02. Dolby Laboratories had a net margin of 16.70% and a return on equity of 11.08%. The business had revenue of $305.00 million for the quarter, compared to analyst estimates of $311.96 million. During the same quarter in the previous year, the firm posted $0.78 earnings per share. Dolby Laboratories’s quarterly revenue was down 3.3% on a year-over-year basis. Dolby Laboratories has set its FY 2026 guidance at 4.250-4.400 EPS and its Q4 2026 guidance at 1.130-1.280 EPS. Analysts predict that Dolby Laboratories will post 3.23 earnings per share for the current year.

Dolby Laboratories Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Wednesday, August 19th. Stockholders of record on Tuesday, August 11th were given a $0.36 dividend. This represents a $1.44 annualized dividend and a dividend yield of 2.3%. The ex-dividend date of this dividend was Tuesday, August 11th. Dolby Laboratories’s payout ratio is currently 61.28%.

Dolby Laboratories declared that its Board of Directors has initiated a stock repurchase program on Thursday, July 30th that permits the company to repurchase $350.00 million in outstanding shares. This repurchase authorization permits the electronics maker to repurchase up to 7% of its shares through open market purchases. Shares repurchase programs are usually a sign that the company’s board believes its stock is undervalued.

Insider Transactions at Dolby Laboratories

In other news, SVP John D. Couling sold 7,667 shares of the company’s stock in a transaction on Tuesday, September 1st. The stock was sold at an average price of $61.05, for a total transaction of $468,070.35. Following the transaction, the senior vice president directly owned 118,727 shares of the company’s stock, valued at $7,248,283.35. This represents a 6.07% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Also, CAO Ryan Nicholson sold 1,348 shares of the company’s stock in a transaction dated Monday, August 10th. The shares were sold at an average price of $62.04, for a total transaction of $83,629.92. Following the transaction, the chief accounting officer owned 35,636 shares in the company, valued at $2,210,857.44. This represents a 3.64% decrease in their position. The disclosure for this sale is available in the SEC filing. Over the last 90 days, insiders have sold 28,889 shares of company stock worth $1,706,606. Corporate insiders own 37.93% of the company’s stock.

Dolby Laboratories Company Profile

(Free Report)

Dolby Laboratories, Inc is a global leader in audio and imaging technologies, specializing in the development, licensing and deployment of solutions that enhance entertainment and communications experiences. The company’s core business revolves around creating advanced audio codecs, noise reduction systems and spatial sound technologies for a wide range of applications, including cinema, broadcast, gaming, streaming and personal devices. Dolby’s licensing model enables consumer electronics manufacturers, content creators and service providers to integrate its technologies into products such as televisions, smartphones, home theater systems and set-top boxes.

Among its flagship innovations are Dolby Atmos, an immersive audio format that delivers three-dimensional soundscapes for theaters and home systems; Dolby Digital and Dolby Digital Plus, widely adopted audio compression formats for broadcast and streaming; and Dolby Vision, a high-dynamic-range imaging technology that expands color, contrast and brightness in displays.

Further Reading

Want to see what other hedge funds are holding DLB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Dolby Laboratories (NYSE:DLBFree Report).

Institutional Ownership by Quarter for Dolby Laboratories (NYSE:DLB)

Receive News & Ratings for Dolby Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dolby Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.